Grey Wolf Therapeutics completes £10 million ($14 million) series A financing with Andera Partners and Canaan to fund development of immuno-oncology therapies to increase tumour visibility

from Venture Capital Access Online: Latest Venture Capital and Private Equity News http://bit.ly/2BqBhyv
via IFTTT